|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,053 JPY | -1.12% |
|
-2.41% | -0.02% |
| Apr. 30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
| Apr. 26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
Sept 15 (Reuters) - Japanese pharma company Takeda Pharmaceutical Co said on Wednesday the U.S. Food and Drug Administration has granted an accelerated approval to its drug, Exkivity, to treat a type of lung cancer. (Reporting by Dania Nadeem in Bengaluru; Editing by Shailesh Kuber)
| 1st Jan change | Capi. | |
|---|---|---|
| -0.02% | 41.63B | |
| +32.95% | 700B | |
| -4.97% | 358B | |
| +18.83% | 330B | |
| +3.54% | 287B | |
| +15.70% | 236B | |
| +6.68% | 202B | |
| -9.08% | 197B | |
| +6.70% | 161B | |
| -1.81% | 157B |
TAKEDA PHARMACEUTICAL COMPANY LIMITED 